{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:16:44Z","timestamp":1778563004182,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.lungcan.2017.11.016","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T00:00:42Z","timestamp":1511395242000},"page":"64-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The predictive value of the interferon-\u03b3 release assay for chemotherapy responses in patients with advanced non-small-cell lung cancer"],"prefix":"10.1016","volume":"115","author":[{"given":"Hsu-Ching","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Juin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Lu","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Yih","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Hsiung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Hao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Yuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Hua","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2017.11.016_bib0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3892\/ol.2014.2777","article-title":"Clinical investigation into the initial diagnosis and treatment of 1,168 lung cancer patients","volume":"9","author":"Shao","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0015","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1073\/pnas.0901329106","article-title":"Impaired interferon signaling is a common immune defect in human cancer","volume":"106","author":"Critchley-Thorne","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/bjc.2015.398","article-title":"Activation of IFN\/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer","volume":"114","author":"Legrier","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lungcan.2017.11.016_bib0025","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.lungcan.2014.07.001","article-title":"Latent TB infection in newly diagnosed lung cancer patients ? A multicenter prospective observational study","volume":"85","author":"Fan","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2017.11.016_bib0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrclinonc.2010.223","article-title":"Immune parameters affecting the efficacy of chemotherapeutic regimens","volume":"8","author":"Zitvogel","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/onc.2012.39","article-title":"IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer","volume":"32","author":"Guo","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2017.11.016_bib0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1465-9921-7-56","article-title":"Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test","volume":"7","author":"Brock","year":"2006","journal-title":"Respir. Res."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0045","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1183\/09031936.00122109","article-title":"Indeterminate results of a tuberculosis-specific interferon-gamma release assay in immunocompromised patients","volume":"35","author":"Lange","year":"2010","journal-title":"Eur. Respir J."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0050","first-page":"286","article-title":"Assessment of an Interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patient","volume":"140","author":"Hoffmann","year":"2010","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0055","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/j.1600-6143.2007.02011.x","article-title":"Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation","volume":"7","author":"Manuel","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1126\/science.149.3681.310","article-title":"Interferon-Like virus-Inhibitor induced in human leukocytes by phytohemagglutinin","volume":"149","author":"Wheelock","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.lungcan.2017.11.016_bib0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1359-6101(01)00038-7","article-title":"The roles of IFN gamma in protection against tumor development and cancer immunoediting","volume":"13","author":"Ikeda","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0070","doi-asserted-by":"crossref","first-page":"13956","DOI":"10.1073\/pnas.96.24.13956","article-title":"Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway","volume":"96","author":"Kovarik","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12929-017-0317-0","article-title":"Escape from IFN-gamma-dependent immunosurveillance in tumorigenesis","volume":"24","author":"Lin","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cei.12392","article-title":"Lung cancer is associated with decreased expression of perforin granzyme B and interferon (IFN)-gamma by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells","volume":"178","author":"Hodge","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0090","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrc.2017.17","article-title":"Prospects for combining targeted and conventional cancer therapy with immunotherapy","volume":"17","author":"Gotwals","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lungcan.2017.11.016_bib0095","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1186\/s12885-016-2597-2","article-title":"Metronomic cyclophosphamide activation of anti-tumor immunity: tumor model, mouse host, and drug schedule dependence of gene responses and their upstream regulators","volume":"16","author":"Wu","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2017.11.016_bib0100","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1158\/1078-0432.CCR-14-1298","article-title":"Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence","volume":"20","author":"de Biasi","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0105","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1158\/1078-0432.CCR-13-3141","article-title":"Molecular pathways: the immunogenic effects of platinum-based chemotherapeutics","volume":"20","author":"Hato","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0110","first-page":"296","article-title":"Chemotherapy outcomes in advanced non-small-cell lung carcinoma","volume":"20","author":"Liu","year":"1993","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/cdd.2013.67","article-title":"Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer","volume":"21","author":"Bracci","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0120","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2017.11.016_bib0125","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discov."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500217305834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500217305834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T13:15:49Z","timestamp":1570367749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500217305834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":25,"alternative-id":["S0169500217305834"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2017.11.016","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The predictive value of the interferon-\u03b3 release assay for chemotherapy responses in patients with advanced non-small-cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2017.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}